The Greater Philadelphia area has long been a vibrant hub of biotech and pharmaceutical industry. Over the last three decades, scientists and entrepreneurs in the Greater Philadelphia region have held the global leadership in the discovery and development of Cell and Gene therapies. Four FDA-approved therapies have originated here, including the first cell therapy (Kymriah®) […]
Spotlight: 17 Start-up Companies from Big4Bio Regions are Showcased at BIO 2022
/ big4bio
This is part 2 of Big4Bio’s coverage of the 44 early and seed stage companies that presented at this year’s Start-up Stadium held during the BIO 2022 conference in San Diego. By Cassie Arnold Part 1 of Big4Bio’s coverage of the Start-up Stadium at BIO 2022 covered the criteria and process for all of the […]
Spotlight: Start-up Stadium Coverage at BIO 2022
/ big4bio
by Cassie Arnold Forty-four early and seed stage companies are presenting at this year’s Start-up Stadium held during the BIO 2022 Conference in San Diego. These companies were selected to present live during the conference from among the more than 150 companies that submitted applications including their pitch decks in April. The applications were reviewed […]
Event Spotlight: The Board Meeting by CRUSH Life Sciences
/ big4bio
CRUSH Life Sciences was founded in 2018 by industry colleagues Laurie Halloran, President & CEO of Halloran Consulting Group, Doug MacDougall, Managing Partner at MacDougall Advisors, and Geoff Meyerson, CEO & Co-Founder of Locust Walk. These entrepreneurs discussed ways to bring together a community of executives for off-the-record chats to talk through successes, challenges, and […]
Spotlight Q&A: The Story of XiltriX
/ big4bio
Stephen Tierney is the President at XiltriX North America, and is based in San Diego, California Big4Bio: What is the story of XiltriX? Tierney: XiltriX North America was established to make science safer and more predictable through technology. Over the past 30 years, XiltriX has been developed in-house by our sister company in the Netherlands. […]
Spotlight: Event Recap from 2021 DEI Report
/ big4bio
NOTE: On December 8th, Big4Bio:Philadelphia sponsor Life Sciences Pennsylvania (LSPA) conducted a virtual leadership panel with representatives from three different industries to discuss their culture, hiring practices, and managing the changing landscape of the workforce. Part 1 of a transcript recap of this event is included in our just-published 2021 DEI Report; part 2 continues […]
Spotlight: The Biotech Showcase Returns to San Francisco as a Hybrid Event
/ big4bio
The Big4Bio Podcast · The Biotech Showcase Returns to San Francisco as a Hybrid Event BioWeekSF (aka “JPM” or “JPM Week”) is the second week in January in SF that kicks off the new year in industry dealmaking/partnering. We call it “BioWeekSF” as there are many additional, important events that go on outside and beyond […]
Spotlight: Keeping the Life Sciences Workplace Safe
/ big4bio
The Big4Bio Podcast · Keeping the Life Sciences Workplace Safe
Spotlight: Quintara Discovery — A CRO Where No Project is Too Big or Too Small
Marie Daghlian Quintara Discovery, Inc prides itself for being a flexible partner in biotech companies’ drug discovery and development efforts. Based in the San Francisco Bay Area, it provides high-quality drug discovery services to the vibrant biotech community in the region and beyond, including in vitro ADME profiling, bioanalysis services, and dedicated assay development and […]
Spotlight: Quintara Discovery — A CRO Where No Project is Too Big or Too Small
Marie Daghlian Quintara Discovery, Inc prides itself for being a flexible partner in biotech companies’ drug discovery and development efforts. Based in the San Francisco Bay Area, it provides high-quality drug discovery services to the vibrant biotech community in the region and beyond, including in vitro ADME profiling, bioanalysis services, and dedicated assay development and […]
Spotlight: Quintara Discovery — A CRO Where No Project is Too Big or Too Small
Marie Daghlian Quintara Discovery, Inc prides itself for being a flexible partner in biotech companies’ drug discovery and development efforts. Based in the San Francisco Bay Area, it provides high-quality drug discovery services to the vibrant biotech community in the region and beyond, including in vitro ADME profiling, bioanalysis services, and dedicated assay development and […]
Spotlight: Quintara Discovery — A CRO Where No Project is Too Big or Too Small
/ big4bio
Marie Daghlian Quintara Discovery, Inc prides itself for being a flexible partner in biotech companies’ drug discovery and development efforts. Based in the San Francisco Bay Area, it provides high-quality drug discovery services to the vibrant biotech community in the region and beyond, including in vitro ADME profiling, bioanalysis services, and dedicated assay development and […]
Spotlight: The 2021 Life Sciences Workforce Trends Report for California
/ big4bio
Big4Bio sponsors Biocom and CLS have published a joint report, “2021 Life Sciences Workforce Trends,” which includes the most pressing current and projected talent needs of California’s life sciences industry, a constantly-leading driver of employment across the state. The three foundational datasets described, include the number of job postings from January 2017 to December 2020, […]
Podcast: The Write Stuff — Reinventing the Synthesis of DNA With Enzymes
/ big4bio
Companies to Watch – Molecular Assemblies The Big4Bio Podcast · The Write Stuff: Reinventing the Synthesis of DNA with Enzymes Molecular Assemblies’ President and CEO Mike Kamdar and Co-Founder and Chief Scientific Officer Bill Efcavitch talk more about the company’s enzymatic synthesis of DNA and its plans for commercialization. NEXT WEEK: Q&A with Molecular […]
Spotlight Q&A with Stephen Ghiglieri, Danforth Advisors
/ big4bio
Stephen Ghiglieri is a veteran corporate officer of life science companies and a newly-appointed Managing Director of the Western Region for Danforth Advisors Big4Bio: As an experienced finance and operations executive, what attracted you to the life sciences? SG: I have spent the majority of my career in life sciences, but it was a departure […]